Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
BNTX
BNTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BNTX News
BioNTech (BNTX.US) Executive Plans to Sell $93.87 Million in Common Stock via Form 144
3d ago
moomoo
Pfizer Shares Decline Despite Strong Earnings: Concerns for Wall Street.
Feb 03 2026
Barron's
Oncolytics Biotech Strengthens Leadership Amid Oncology Market Surge
Jan 28 2026
PRnewswire
Oncolytics Biotech Strengthens Leadership to Advance Clinical Programs
Jan 28 2026
Newsfilter
Investment Strategy Analysis for Biotech Stocks
Jan 27 2026
Fool
Analysis of FBT Stock's 52-Week High and Low Points
Jan 27 2026
NASDAQ.COM
HHS Secretary Robert F. Kennedy Jr. Dismisses Four Childhood Vaccine Advisors, Impacting Vaccine Injury Compensation Program
Jan 20 2026
seekingalpha
Goldman Sachs Upgrades BioNTech (BNTX) to Buy, Raises Price Target to $142
Jan 16 2026
stocktwits
Stocks to Consider Buying in 2026: Insights from Our Roundtable Experts, Including DoorDash and LVMH
Jan 16 2026
Barron's
Deutsche Bank Upgrades Coupang to Buy, Strong Regulatory Resilience
Jan 16 2026
CNBC
Topgolf Callaway and Others See Analyst Upgrades with Significant Price Target Increases
Jan 16 2026
Benzinga
Oncolytics Biotech Appoints New Executives to Accelerate Cancer Treatment Progress
Jan 14 2026
Globenewswire
HHS Secretary Kennedy Appoints Two OB-GYN Experts to CDC's ACIP
Jan 13 2026
seekingalpha
BioNTech (BNTX) to Advance Multi-Product Oncology Strategy in 2026
Jan 12 2026
seekingalpha
Trump Threatens to Annex Greenland; Denmark to Invest $13.8 Billion in Defense
Jan 07 2026
CNBC
Genmab Discontinues Acasunlimab Development, Focuses on High-Potential Programs
Dec 29 2025
Benzinga
Show More News
